Skip to main content

and
  1. No Access

    Article

    Autologous hematopoietic stem cell transplantation—what determines the outcome: an experience from North India

    Limited information is available from develo** countries about complications, pattern of infections, and long-term outcome of patients following high-dose chemotherapy (HDCT) and autologous blood stem cell t...

    Lalit Kumar, Prabhat Singh Malik, Gaurav Prakash, Ram Prabu in Annals of Hematology (2011)

  2. Article

    Open Access

    Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS

    BEAM (BCNU, etoposide, cytarabine, melphalan) is the most widely used high dose chemotherapy regimen for autologous transplant in lymphoid malignancies. We report our early experience with an alternative regim...

    Atul Sharma, Smita Kayal, Sobuhi Iqbal, Prabhat Singh Malik, Vinod Raina in SpringerPlus (2013)

  3. No Access

    Article

    Prognostic Relevance of T Regulatory Cells in Patients with Advanced-Stage Serous Carcinoma Ovary

    Despite improved treatment options, recurrence rates remain high in ovarian cancer. Tumor microenvironment, particularly T cells, plays an important role in its natural history. The present study was conducted...

    Saphalta Baghmar, Lalit Kumar, Lata Rani in Indian Journal of Gynecologic Oncology (2016)

  4. Article

    Open Access

    Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma

    We investigated the impact of renal impairment (RI) on the outcome in multiple myeloma (MM) patients following induction and autologous stem cell transplantation (ASCT). Among 349 patients who received a first...

    Lalit Kumar, Santosh Kumar Chellapuram, Ramavat Dev in Clinical Hematology International (2019)

  5. No Access

    Article

    Differential expression of circulating serum miR-1249-3p, miR-3195, and miR-3692-3p in non-small cell lung cancer

    Global deregulation in miRNA expression is a hallmark of cancer cell. An estimated 2300 mature miRNAs are encoded by human genome; role of many of which in carcinogenesis and as cancer biomarkers remains unexp...

    Sachin Kumar, Surender K. Sharawat, Ashraf Ali, Vikas Gaur in Human Cell (2020)

  6. No Access

    Article

    PD-L1 Expression in Small Cell and Large Cell Neuroendocrine Carcinomas of Lung: an Immunohistochemical Study with Review of Literature

    High-grade neuroendocrine tumors (HGNET) have distinctive tumor biology/behaviour. Newer modalities of treatment (immunotherapy) for them have been included in recent NCCN guidelines. Detection of programmed d...

    Prerna Guleria, Sunil Kumar, Prabhat Singh Malik in Pathology & Oncology Research (2020)

  7. Article

    Open Access

    Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLC

    Early diagnosis is crucial for effective medical management of cancer patients. Tissue biopsy has been widely used for cancer diagnosis, but its invasive nature limits its application, especially when repeated...

    Chitrita Goswami, Smriti Chawla, Deepshi Thakral, Himanshu Pant in BMC Genomics (2020)

  8. Article

    Open Access

    Correction to: Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLC

    An amendment to this paper has been published and can be accessed via the original article.

    Chitrita Goswami, Smriti Chawla, Deepshi Thakral, Himanshu Pant in BMC Genomics (2020)

  9. No Access

    Article

    Poems syndrome: consolidation with autologous stem cell transplantation

    Annie K. Baa, Santosh K. Chellapuram, Atul Sharma in Bone Marrow Transplantation (2021)

  10. No Access

    Article

    Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women

    In this study, we evaluate the cost and outcomes of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) plus fulvestrant, fulvestrant alone, and conventional chemotherapy as the second-line therapy for hormone re...

    Nidhi Gupta, Dharna Gupta, Jyoti Dixit in Applied Health Economics and Health Policy (2022)

  11. Article

    Open Access

    Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel

    Peripheral neuropathy is a common dose-limiting side effect of paclitaxel. To date, there is no effective strategy to prevent paclitaxel-induced peripheral neuropathy. A recent small phase II study demonstrate...

    Praful Pandey, Akash Kumar, Deepam Pushpam, Sachin Khurana, Prabhat Singh Malik in Trials (2023)

  12. Article

    Open Access

    Map** the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples

    Small cell lung carcinomas (SCLC) are aggressive tumors with high propensity to metastasize. Recent NCCN guidelines have incorporated immunotherapy in extensive stage SCLC. Limited benefit in few patients comp...

    Rimlee Dutta, Amber Rathor, Hanuman Prasad Sharma, Hem Chandra Pandey in Scientific Reports (2023)

  13. No Access

    Article

    Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study

    This phase II trial is designed to test whether the performance status (PS) of metastatic non-small cell lung cancer (mNSCLC) patients (pts) can improve with chemotherapy if their poor PS (Eastern Cooperative ...

    Neha Pathak, Rakesh Garg, Sachin Khurana in Journal of Cancer Research and Clinical On… (2023)

  14. No Access

    Article

    Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution

    Chronic myeloid leukemia (CML) management during pregnancy is challenging. In this retrospective study, hospital records of CML patients treated between 2000 and 2021 were screened to identify patients who tri...

    Chethan R, Prabhat Singh Malik, Ranjit Kumar Sahoo in Annals of Hematology (2023)